Cytokeratin 5 Antibody

Skip to product information
1 of 2

Selleck Chemicals

SKU:F2681-20UL

Regular price €199,00 EUR
Regular price Sale price €199,00 EUR
Sale Sold out
Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

Cytokeratin 5 (CK5) is a type II keratin protein encoded by the KRT5 gene, primarily expressed in the basal layer of stratified epithelial tissues such as skin and mucosal linings. It forms heterodimers with Cytokeratin 14 (CK14), assembling into intermediate filaments that provide structural support and mechanical resilience to epithelial cells. Depending on the literature source, KRT5 may also be discussed as Cytokeratin 5 and 58 kDa cytokeratin.

Reported cellular context includes cytoplasm, intermediate filament, and keratin, which can matter when signal is compared across treatments or changing cell states. Following KRT5 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

KRT5 is commonly interpreted in the context of cancer research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm, intermediate filament, and keratin, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between cytoplasm, intermediate filament, and keratin across matched conditions
  • changes associated with proliferative state, oncogenic signaling, or treatment response
  • co-patterning with orthogonal markers and control conditions that clarify pathway state
  • time-matched comparisons so changes reflect biology rather than handling or sampling drift

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for KRT5. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in KRT5 reflect biology rather than handling. When interpreting KRT5, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep KRT5 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
KRT5
Research Area:
Cancer
Application:
IF • IHC • WB
Reactivity:
Human • Mouse • Rat
Specificity:
Cytokeratin 5 Antibody [G20N20] recognizes endogenous levels of total Cytokeratin 5 protein. Immunoblotting results showed that this antibody cross-reacted with cytokeratin 6, while it exhibited weak reactivity with cytokeratin 4.
Host:
Mouse
Clonality:
Monoclonal
Clone:
G20N20
UniProt:
P13647
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.